ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NXG Nexgenrx Inc

0.28
0.00 (0.00%)
28 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Nexgenrx Inc TSXV:NXG TSX Venture Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.28 0.30 0.345 0 12:30:02

NexgenRx Announces First Quarter of 2014 Results

28/05/2014 9:12pm

Marketwired Canada


NEXGENRX INC. ("NexgenRx" or the "Corporation") (TSX VENTURE:NXG) is pleased to
announce its first quarter of 2014 results.


For the first quarter ended March 31, 2014 transaction and administration
revenue was $1,034,006, generating gross profit of $817,261 and a net loss was
$58,500.


"In the first quarter of 2014, while our new sales revenue increased, we did
feel the full impact of one of our major client's decisions to migrate their
claims processing in house. The loss of this revenue was partially offset by our
new sales revenue and organic growth of over $300,000 during the quarter which
provides the confidence in our ability to recover the lost revenue during the
year." stated Ron Loucks, President and CEO.


About NexgenRx

NexgenRx is a growing health benefits management company engaged in the design,
management and administration of health benefit plans offered by employers and
other plan sponsors for the benefit of their employees and plan members. More
information on NexgenRx can be found at www.nexgenrx.com.


Caution Regarding Forward-Looking Statements - This news release contains
certain forward looking statements, including statements regarding the business
and anticipated financial performance of the Corporation. These statements are
subject to a number of risks and uncertainties. Actual results may differ
materially from results contemplated by the forward-looking statements. When
relying on forward-looking statements to make decisions, investors and others
should carefully consider the foregoing factors and other uncertainties and
should not place undue reliance on such forward-looking statements.


"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts responsibility
for the adequacy or accuracy of the release."


FOR FURTHER INFORMATION PLEASE CONTACT: 
NexgenRx Inc.
Ronald C. Loucks
President and CEO
416.695.3393 x801


NexgenRx Inc.
Taba Merrikh
Director of Finance
416-695-3393x803
www.nexgenrx.com

1 Year Nexgenrx Chart

1 Year Nexgenrx Chart

1 Month Nexgenrx Chart

1 Month Nexgenrx Chart

Your Recent History

Delayed Upgrade Clock